Supreme Court Proposes 16% MRP Cap on Essential Medicines
The Supreme Court expressed concern over inflated prices of essential medicines, especially cancer drugs, sold at high markups. Justices Vikram Nath and SVN Bhatti criticized pharmaceutical companies for ignoring public hardships and urged the government to implement a uniform pricing rule capping maximum retail prices at 16%. The court noted the financial burden on taxpayers due to inflated reimbursements under public health schemes.
Economic Times·4h ago




